Search Within

Sridevi Rajeeve

Formats
  1. Meeting Abstract (26)
  2. Journal Article (5)
  3. Review (2)
  4. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (28)
  2. Department of Medicine (28)
  3. Hematologic Malignancies, Division of (28)
  4. Myeloma (28)
  5. Bone Marrow Transplant (26)
  6. CTCR Scholars (26)

More Groups

People
  1. Sham Mailankody (28)
  2. Saad Usmani (27)
  3. Alexander Lesokhin (26)
  4. Carlyn Rose Tan (26)
  5. David Chung (26)
  6. Heather Landau (26)

More People

Years
  1. 2025 (2)
  2. 2024 (26)
  3. 2023 (6)
Publications
  1. Blood (14)
  2. Clinical Lymphoma, Myeloma and Leukemia (11)
  3. Blood Advances (2)
  4. Journal of Clinical Oncology (2)
  5. American Journal of Hematology (1)
  6. Blood Cancer Journal (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Elsevier Inc. (11)
  3. American Society of Clinical Oncology (2)
  4. Frontiers Media S.A. (1)
  5. John Wiley & Sons (1)
  6. Nature Publishing Group (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early and consistent CRS detection using wearable device for remote patient monitoring following CAR-T therapy in relapsed/refractory multiple myeloma (RRMM): Early results of an investigator-initiated trial
    Meeting Abstract

    Rajeeve, S.; Zahradka, N.; Wilkes, M.; Pan, D.; Calafat, N. J.; Serebryakova, K.; Kappes, K.; Jackson, H.; Buchenholz, N.; Agte, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Carfilzomib,lenalidomide and dexamethasone (KRd) as induction therapy in high-risk newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Korde, N.; Derkach, A.; Hultcrantz, M.; Maclachlan, K. H.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bendamustine-based bridging versus standard of care approaches: A comparison of toxicity profiles of bridging therapy in multiple myeloma patients undergoing CAR T cell therapy
    Meeting Abstract

    Yan, L.; Sridevi, R.; Sheng, T.; Marcio, D.; Shambavi, R.; Sundar, J.; Adriana, R.
    American Journal of Hematology (2023)

    Fulltext@MSK | Save